Literature DB >> 19925785

Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats.

Wenhui Zhang1, Laurence Fievez, Esteban Cheu, Fabrice Bureau, Weifang Rong, Fan Zhang, Yong Zhang, Charles Advenier, Pascal Gustin.   

Abstract

In this study, the anti-inflammatory properties of formoterol and ipratropium bromide, alone or in combination, were investigated in a rat model of acute pulmonary inflammation induced by cadmium inhalation. Airway resistance and inflammatory responses, including matrix metalloproteinease-2 (MMP-2) and matrix metalloproteinease-9 (MMP-9) activities, were evaluated. Compared to values obtained in rats exposed to cadmium, pretreatment by bronchodilators administered alone significantly prevented the cadmium-induced increase of airway resistance. Formoterol elicited a significant decrease in total cell number, neutrophil and macrophage counts in bronchoalveolar lavage fluid, whereas ipratropium bromide reduced neutrophil numbers. The two compounds administered alone significantly attenuated the lung lesions associated with parenchyma inflammatory cell influx and congestion observed in the cadmium group. The increased MMP-9 activity was significantly attenuated. Although only formoterol induced a decrease protein concentration in bronchoalveolar lavage fluid, both compounds inhibited the pulmonary edema by reducing wet-to-dry weight ratio which returned to values similar to those recorded in the sham group. All the effects of formoterol on the cadmium-induced inflammatory responses were reversed by propranolol. Similar anti-inflammatory effects were obtained in rats pretreated with ilomastat which showed a significant reduction on inflammatory cell infiltration and MMP-9 activity in bronchoalveolar lavage fluid. Neither synergistic nor additive effects were obtained when the two bronchodilators were administered in combination. In conclusion, formoterol and ipratropium bromide partially protect the lungs against the inflammation by reducing neutrophilic infiltration. This protective effect is associated with reduced MMP-9 activity known to play an important pro-inflammatory role in acute inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925785     DOI: 10.1016/j.ejphar.2009.11.015

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Chronic obstructive pulmonary disease associated with increased risk of bipolar disorder.

Authors:  Vincent Yi-Fong Su; Li-Yu Hu; Chiu-Mei Yeh; Huey-Ling Chiang; Cheng-Che Shen; Kun-Ta Chou; Tzeng-Ji Chen; Ti Lu; Cheng-Hwai Tzeng; Chia-Jen Liu
Journal:  Chron Respir Dis       Date:  2016-01-01       Impact factor: 2.444

3.  Repeated stress down-regulates β(2)- and α (2C)-adrenergic receptors and up-regulates gene expression of IL-6 in the rat spleen.

Authors:  Marcela Laukova; Peter Vargovic; Olga Krizanova; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2010-07-06       Impact factor: 5.046

4.  Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.

Authors:  Hussam A Murad; Hamed S Habib; Misbahuddin M Rafeeq; Mansour I Sulaiman; Amer S Abdulrahman; Mohamad Nidal Khabaz
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

5.  Evaluation of oxidative stress, inflammation, apoptosis, oxidative DNA damage and metalloproteinases in the lungs of rats treated with cadmium and carvacrol.

Authors:  Kerim Yesildag; Cihan Gur; Mustafa Ileriturk; Fatih Mehmet Kandemir
Journal:  Mol Biol Rep       Date:  2021-11-18       Impact factor: 2.316

Review 6.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

7.  Differences of the Nasal Microbiome and Mycobiome by Clinical Characteristics of COPD Patients.

Authors:  Maura Alvarez Baumgartner; Chengchen Li; Thomas M Kuntz; Lina Nurhussien; Andrew J Synn; Wendy Y Sun; Jennifer E Kang; Peggy S Lai; Jeremy E Wilkinson; Mary B Rice
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

8.  Mitigation of cadmium-induced lung injury by Nigella sativa oil.

Authors:  Ahmad A El-Ebiary; Sabah El-Ghaiesh; Ehab Hantash; Suliman Alomar
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-01       Impact factor: 4.223

9.  Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism.

Authors:  Hulya Uzkeser; Elif Cadirci; Zekai Halici; Fehmi Odabasoglu; Beyzagul Polat; Tugba Nurcan Yuksel; Seda Ozaltin; Fadime Atalay
Journal:  Mediators Inflamm       Date:  2012-05-14       Impact factor: 4.711

10.  Impaired structural and functional regeneration of skeletal muscles from β2-adrenoceptor knockout mice.

Authors:  M T Silva; L A Wensing; P C Brum; N O Câmara; E H Miyabara
Journal:  Acta Physiol (Oxf)       Date:  2014-07-04       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.